Applications to the NRECs for Clinical Trials of Investigational Medicinal Products (NREC-CT) can be submitted at any stage until the submission cut-off date for the next NREC meeting (see table below).

All applications must be submitted to the National Office by 12 noon on the cut-off date to be considered at the next NREC-CT meeting.

From 01 February 2023, all applications must be submitted under the Clinical Trial Regulation (CTR) via the CTIS system.

Applications received under the CTD by the last cut off date of 25th January 2023, which are deemed invalid, must be subsequently resubmitted under the CTR.

Depending on the volume of applications received ahead of the cut-off date, the Chair of the NREC-CTs in consultation with the Programme Manager may need to limit the number of applications reviewed at any given meeting in order to manage workflow and ensure consistent high-quality ethics review.

The submission cut-off dates relate to the submission of a ‘Valid’ application. All applications deemed as ‘Invalid’ by the National Office will require resubmission for consideration by the NREC-CT.

Apply to the NREC-CT.